Anavex Life Sciences Corp (AVXL)

[BAR123]

This has nothing to do with “this particular stock manipulation and takedown”. The stock price is due to Missling’s consistent strategy of promising a lot and delivering even less. His constant missteps as ceo include missed deadlines, bumbling of data releases, hiring mediocre cro’s, not hiring a great stats guy 2 years ago, not hiring enough staff to move pipeline along faster, not partnering soon enough to get the drug into patients hands sooner, not dealing with the short attacks or AF, not going for approval in Australia before fda,…. I can go on but you get the point.

Now the ceo goes into hiding for the last 6 months or so and we are all left in the dark with a depressed share price.